Benchmark gives Semler Scientific a "Buy" rating, with a target price set at $101

On July 8, according to CoinDesk, brokerage firm Benchmark has given Semler Scientific a "buy" rating and set its stock target price at $101, with analyst Mark Palmer saying he is optimistic about the company's transition from medical diagnostics to a Bitcoin reserve strategy. The company has acquired approximately 4,636 Bitcoins for $430 million, with an average cost basis of $92,753 per Bitcoin. [Deep Tide TechFlow]